Clinical Trial Update: Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the biologic activity and safety of an immunotherapeutic in newly diagnosed advanced renal cell carcinoma, tested in combination with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Immunotherapeutic (investigational agent in study)

Snippet

Sponsor: Argos Therapeutics | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED